The stock of Wright Medical Group Inc (NASDAQ:WMGI) reached all time high today, Mar, 21 and still has $31.36 target or 5.00% above today’s $29.87 share price. This indicates more upside for the $1.56 billion company. This technical setup was reported by Barchart.com. If the $31.36 PT is reached, the company will be worth $78.00M more. About 1.27M shares traded or 24.51% up from the average. Wright Medical Group Inc (NASDAQ:WMGI) has risen 21.56% since August 12, 2016 and is uptrending. It has outperformed by 12.88% the S&P500.
K2m Group Holdings Incorporated (NASDAQ:KTWO) had a decrease of 2.17% in short interest. KTWO’s SI was 3.09M shares in March as released by FINRA. Its down 2.17% from 3.16 million shares previously. With 420,400 avg volume, 7 days are for K2m Group Holdings Incorporated (NASDAQ:KTWO)’s short sellers to cover KTWO’s short positions. The SI to K2m Group Holdings Incorporated’s float is 17.78%. About 88,053 shares traded. K2M Group Holdings Inc (NASDAQ:KTWO) has risen 16.44% since August 12, 2016 and is uptrending. It has outperformed by 7.76% the S&P500.
K2M Group Holdings, Inc. is a medical device firm focused on designing, developing and commercializing spine technologies and techniques. The company has market cap of $811.10 million. The Company’s spine products are used by spine surgeons to treat spinal pathologies, such as deformity , trauma and tumor. It currently has negative earnings. The Firm is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions.
Among 8 analysts covering K2M Group Holdings (NASDAQ:KTWO), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. K2M Group Holdings had 12 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Tuesday, May 3 by Northland Capital. The rating was initiated by Gabelli with “Buy” on Friday, September 16. The rating was maintained by Piper Jaffray on Thursday, August 27 with “Overweight”. Barclays Capital maintained it with “Overweight” rating and $22 target in Thursday, August 4 report. The firm earned “Outperform” rating on Monday, October 10 by RBC Capital Markets. As per Wednesday, August 5, the company rating was maintained by Piper Jaffray. On Friday, April 8 the stock rating was initiated by JMP Securities with “Market Outperform”. Needham upgraded K2M Group Holdings Inc (NASDAQ:KTWO) on Monday, May 23 to “Strong Buy” rating. The firm has “Outperform” rating given on Tuesday, July 19 by Oppenheimer. The rating was initiated by UBS with “Buy” on Tuesday, September 22.
Analysts await Wright Medical Group Inc (NASDAQ:WMGI) to report earnings on May, 3. They expect $-0.08 earnings per share, up 33.33% or $0.04 from last year’s $-0.12 per share. After $-0.06 actual earnings per share reported by Wright Medical Group Inc for the previous quarter, Wall Street now forecasts 33.33% negative EPS growth.
Among 14 analysts covering Wright Medical Group (NASDAQ:WMGI), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Wright Medical Group had 19 analyst reports since August 20, 2015 according to SRatingsIntel. The company was upgraded on Monday, November 30 by Jefferies. The firm has “Buy” rating given on Tuesday, September 22 by UBS. The rating was maintained by Leerink Swann on Thursday, September 3 with “Outperform”. Oppenheimer maintained the stock with “Perform” rating in Monday, November 30 report. The rating was downgraded by Guggenheim on Tuesday, January 3 to “Neutral”. The firm earned “Buy” rating on Wednesday, November 4 by Sterne Agee CRT. RBC Capital Markets maintained Wright Medical Group Inc (NASDAQ:WMGI) on Tuesday, November 10 with “Outperform” rating. The firm has “Buy” rating by Guggenheim given on Thursday, June 9. The rating was maintained by Piper Jaffray with “Hold” on Wednesday, September 2. The firm has “Hold” rating by Needham given on Thursday, September 3.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The company has market cap of $1.56 billion. The Firm through Wright Medical Technology, Inc. and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. It currently has negative earnings. The Firm operates through three divisions: U.S., International and BioMimetic.
